NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 156 filers reported holding NEVRO CORP in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $555 | -49.9% | 28,867 | -33.8% | 0.03% | -45.8% |
Q2 2023 | $1,108 | -11.9% | 43,597 | +25.4% | 0.05% | -18.6% |
Q1 2023 | $1,257 | -6.8% | 34,767 | +2.1% | 0.06% | -21.3% |
Q4 2022 | $1,348 | -99.9% | 34,039 | -4.6% | 0.08% | -25.0% |
Q3 2022 | $1,663,000 | +154.7% | 35,679 | +139.6% | 0.10% | +104.1% |
Q2 2022 | $653,000 | +99.7% | 14,890 | +429.1% | 0.05% | +11.4% |
Q3 2021 | $327,000 | – | 2,814 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |